Companies testing next best thing to a coronavirus vaccine: an antibody drug Hirota told Global News the research is essentially a study on the entry points of viruses in the human body.
In simpler terms, Hirota says every virus needs to find “the door to the house” to get into a cell.“If we figure out what those doors are, maybe we can barricade them, maybe we can lock them,” Hirota said.At present, world scientists believe the entry of SARS-CoV-2 (COVID-19) into cells occurs through a receptor on the cell surface, known as Angiotensin-converting enzyme 2 (ACE2), which is present in the cells of most organs including tissue of the lung type II alveolar cells.But co-lead Andrew Doxey, professor of biology at the University of Waterloo,.